IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 223 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,076,000 | -3.5% | 184,731 | +10.7% | 0.01% | +28.6% |
| Q4 2021 | $3,187,000 | -15.0% | 166,941 | +9.8% | 0.01% | -22.2% |
| Q3 2021 | $3,748,000 | -4.5% | 152,001 | +0.8% | 0.01% | -10.0% |
| Q2 2021 | $3,925,000 | +84.6% | 150,839 | +124.6% | 0.01% | +66.7% |
| Q1 2021 | $2,126,000 | -70.5% | 67,145 | -56.7% | 0.01% | -70.0% |
| Q4 2020 | $7,196,000 | +2.9% | 155,090 | -27.0% | 0.02% | -20.0% |
| Q3 2020 | $6,993,000 | +61.4% | 212,417 | +34.6% | 0.02% | +47.1% |
| Q2 2020 | $4,332,000 | -25.5% | 157,822 | -18.7% | 0.02% | -46.9% |
| Q1 2020 | $5,811,000 | +58.0% | 194,138 | +46.1% | 0.03% | +60.0% |
| Q4 2019 | $3,679,000 | +850.6% | 132,894 | +524.4% | 0.02% | +900.0% |
| Q3 2019 | $387,000 | – | 21,283 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |